TOX4 and lung adenocarcinoma: Moreover, survival analysis using the Kaplan–Meier plotter revealed that patients with lung adenocarcinoma who had higher TOX4-expressing tumors had shorter overall survival and recurrence than patients with lower TOX4-expressing tumors (Fig. 6D).